Literature DB >> 17138799

ACOG Committee Opinion No. 352: Innovative practice: ethical guidelines.

.   

Abstract

Innovations in medical practice are critical to the advancement of medicine. Good clinicians constantly adapt and modify their clinical approaches in ways they believe will benefit patients. Innovative practice frequently is approached very differently from formal research, which is governed by distinct ethical and regulatory frameworks. Although opinions differ on the distinction between research and innovative practice, the production of generalizable knowledge is one defining characteristic of research. Physicians considering innovative practice must disclose to patients the purpose, benefits, and risks of the proposed treatment, including risks not quantified but plausible. They should attempt an innovative procedure only when familiar with and skilled in its basic components. A clinician should share results, positive or negative, with colleagues and, when feasible, teach successful techniques and procedures to other physicians. Practitioners should be wary of adopting innovative procedures or diagnostic tests on the basis of promotions and marketing when the value of the procedures or tests has not been proved. A practitioner should move an innovative practice into formal research if the innovation represents a significant departure from standard practice, if the innovation carries unknown or potentially significant risks, or if the practitioner's goal is to use data from the innovation to produce generalizable knowledge. If there is any question whether innovative practices should be formalized as research, clinicians should seek advice from the relevant institutional review board.

Entities:  

Mesh:

Year:  2006        PMID: 17138799     DOI: 10.1097/00006250-200612000-00056

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  6 in total

1.  Informed surgical consent for a mesh/graft-augmented vaginal repair of pelvic organ prolapse. Consensus of the 2nd IUGA Grafts Roundtable: optimizing safety and appropriateness of graft use in transvaginal pelvic reconstructive surgery.

Authors:  Dennis Miller; Alfredo L Milani; Suzette E Sutherland; Bonnie Navin; Rebecca G Rogers
Journal:  Int Urogynecol J       Date:  2012-03-07       Impact factor: 2.894

2.  Care Levels for Fetal Therapy Centers.

Authors:  Ahmet A Baschat; Sean B Blackwell; Debnath Chatterjee; James J Cummings; Stephen P Emery; Shinjiro Hirose; Lisa M Hollier; Anthony Johnson; Sarah J Kilpatrick; Francois I Luks; M Kathryn Menard; Lawrence B McCullough; Julie S Moldenhauer; Anita J Moon-Grady; George B Mychaliska; Michael Narvey; Mary E Norton; Mark D Rollins; Eric D Skarsgard; KuoJen Tsao; Barbara B Warner; Abigail Wilpers; Greg Ryan
Journal:  Obstet Gynecol       Date:  2022-05-02       Impact factor: 7.623

3.  Innovative Practice, Clinical Research, and the Ethical Advancement of Medicine.

Authors:  Jake Earl
Journal:  Am J Bioeth       Date:  2019-06       Impact factor: 11.229

Review 4.  Innovative treatment as a precursor to clinical research.

Authors:  David Wendler; Seher Anjum; Peter Williamson
Journal:  J Clin Invest       Date:  2021-08-02       Impact factor: 19.456

Review 5.  Surgical innovation: the ethical agenda: A systematic review.

Authors:  Marike L Broekman; Michelle E Carrière; Annelien L Bredenoord
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

6.  Creating a Distinct Medication-Use System for Children at the Point of Care: The Time is Now.

Authors:  Richard Parrish Ii; Ibolja Cernak
Journal:  Pharmacy (Basel)       Date:  2015-06-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.